Latest News
Seeing smaller than light: How an advanced microscopy technique can help in the fight against cancer and other diseases
October 14, 2022 | Microscopes are some of the most powerful tools in cell biology — but what if the cell component that needs to be imaged is smaller than the wavelengths of visible light? A new study from Professor Chris Yip (ChemE, BME) proposes a solution, one that could help advance research into cancer and other diseases.
New insight into how nanoparticles form could advance technologies from solar cells to medical tests
October 13, 2022 | A research team from U of T Engineering has discovered previously unknown phenomena in the growth of nanoparticles. The insights could open new ways of engineering these tiny structures for a variety of purposes, from designing next-generation solar cells to developing new medical tests and treatments.
New CRAFT Tissue Foundry provides infrastructure dedicated to bioengineering innovation
October 11, 2022 | The Centre for Research and Applications in Fluidic Technologies (CRAFT) has opened a new and expanded Tissue Foundry at the University of Toronto. The new facility builds CRAFT’s fabrication capacity following the launch of its Device Foundry in 2021.
Milica Radisic joins Donnelly Centre
September 19, 2022 | The Donnelly Centre is swelling its ranks of leading researchers with two new faculty appointments.
Recipients of third round of Medicine by Design’s Pivotal Experiment Fund announced
September 1, 2022 | Dr. Omar Khan is one of four researchers are the latest to receive support to spin-off aspects of their Medicine by Design-funded research into an early-stage product or venture as part of Medicine by Design’s Pivotal Experiment Fund, which has distributed more than $2.5-million in funding since its launch in early 2021.
New strategy for delivery of therapeutic proteins could help treat degenerative eye diseases
August 18, 2022 | A U of T Engineering research team has created a new platform that delivers multiple therapeutic proteins to the body, each at its own independently controlled rate. The innovation could help treat degenerative diseases such as age-related macular degeneration (AMD), the leading cause of vision loss for people over 50.